Answers are grounded in this paper and cite their sources.
Cohort study assesses glaucoma risk and prognosis via polygenic risk scores, suggesting new management strategies.
Purpose To investigate the clinical utility of a glaucoma polygenic risk score (PRS) for glaucoma, by benchmarking published glaucoma PRSs and by assessing how the best-performing PRS performs for assessing glaucoma risk, age at onset, and glaucoma prognosis. Design Cohort study. Participants 402,739 individuals in FinnGen, with 21,609 individuals with glaucoma diagnosed after the age of 40. Main Outcome Measures Lifetime risk of glaucoma, the need and escalation of intraocular pressure-lowering medication, need for laser therapies, need for incisional surgery. Methods Fourteen published glaucoma PRSs from the PGS Catalog were comprehensively benchmarked using Cox proportional hazards models. The best-performing PRS was selected to further evaluate the lifetime risk of glaucoma by age 85 years using Kaplan- Meier survival analyses, both alone, and alongside family history information. In addition, the impact of PRS on prognostic outcomes was assessed over a 20-year follow-up period. Results The PRS with the best performance had a hazard ratio (HR) of 3.32 (95% CI, 3.21-3.43) for glaucoma (≥90th PRS percentile vs 20-80th percentile). Lifetime risk of glaucoma increased considerably across PRS categories from 2.5% (95% CI 1.7-3.3%) among individuals in the <1st percentile, to 31.9% (30.5-33.3%) in the 95-99th percentile, and to 45.3% (42.3%-48.1%) in the ≥99th percentile. Family history and PRS contributed independently to glaucoma risk, with the PRS effect size decreasing only by 4.2% when adjusting the PRS effect for FH. Those in the highest PRS decile required more intensive glaucoma care, with higher cumulative incidences of medication escalation (60.6% vs 38.4%), laser therapies (39.8% vs 22.9%), and incisional surgeries (15.8% vs 9.5%) compared to the lowest PRS decile over a 20-year follow-up. Conclusions In this large biobank study, a glaucoma PRS effectively stratified individuals according to their lifetime risk of glaucoma, with substantial stratification evident already by midlife. The PRS provided a more precise risk assessment than family history alone, and it was effective in stratifying individuals based on several prognostic measures, including medical treatment escalation and surgical interventions. These findings support the potential utility of PRS-guided screening and management strategies in glaucoma, with future prospective studies warranted to evaluate the clinical implementation and cost- effectiveness.
No takes yet. Share an insight, caveat, or question.
Tusa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: